38.6 Percent of 9- to 17-Year-Olds Have Received at Least One HPV Vaccine Dose
WEDNESDAY, Feb. 14, 2024 -- In 2022, 38.6 percent of children aged 9 to 17 years had received one or more doses of human papillomavirus (HPV) vaccine, according to a February data brief published by the National Center for Health Statistics. Maria... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 14, 2024 Category: Pharmaceuticals Source Type: news

Women With High-Risk HPV Have Increased Risk for Heart Disease
FRIDAY, Feb. 9, 2024 -- Women with high-risk human papillomavirus (HR-HPV) infection have an increased risk for cardiovascular disease (CVD), according to a study published online Feb. 7 in the European Heart Journal. Hae Suk Cheong, M.D., Ph.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 9, 2024 Category: Pharmaceuticals Source Type: news

Genital HPV infections – what community nurses need to know
Nurse specialist in genitourinary medicine Jodie Crossman provides an update on genital HPV infections, including latest statistics and how to advise patients on current prevention and treatment measures Genital Human Papilloma Virus (HPV) is often a big cause of concern for patients, with media stories and information campaigns largely focused on the life-altering effects of... Read moreThe post Genital HPV infections – what community nurses need to know appeared first on Nursing in Practice. (Source: Nursing in Practice)
Source: Nursing in Practice - February 8, 2024 Category: Nursing Authors: Caroline Price Tags: Sexual health Vaccinations and infections Women's health HPV Source Type: news

High-Risk Strains of HPV Could Raise Women's Odds for Heart Death
WEDNESDAY, Feb. 7, 2024 -- Women are four times more likely to die from heart disease and six times more likely to die from stroke if infected with a high-risk strain of human papillomavirus (HPV), a new study warns.HPV already is known to cause... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 7, 2024 Category: General Medicine Source Type: news

High-Risk HPV in Women Heightens Risk of Heart Disease Death
(MedPage Today) -- Women with high-risk strains of human papillomavirus (HPV) had a far higher risk of death from certain types of cardiovascular disease (CVD), a prospective cohort study from Korea found. Compared to women without high-risk strains... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 7, 2024 Category: Cardiology Source Type: news

Budget 2024: Prescription for cervical cancer vaccine, new medical colleges
The government is planning to include the human papillomavirus (HPV) vaccine in the country's immunisation program, potentially making vaccines to prevent cervical cancer more affordable. Finance Minister Nirmala Sitharaman stated that the government aims to encourage vaccination for girls aged 9 to 14 to prevent cervical cancer. Currently, the HPV vaccine is available in private hospitals at a cost of up to ₹4,000 per dose. Additionally, the government plans to establish more medical colleges and upgrade Anganwadi centers for improved healthcare services and nutrition delivery. (Source: The Economic Times)
Source: The Economic Times - February 1, 2024 Category: Consumer Health News Source Type: news

World Cancer Day 2024
Cancer is a major contributor to global mortality, causing about 1 in every 6 deaths and affecting nearly every household (1). Globally, there were an estimated 20 million new cases of cancer and 9.7 million deaths from cancer in 2022. The cancer burden will increase by about 77% by 2050, further straining health systems, people and communities (2). In the WHO Eastern Mediterranean Region alone, more than 788 000 people were diagnosed with cancer in 2022. This number is projected to double to reach 1.57 million cases by 2045, because of population growth and, more importantly, the high prevalence of cancer risk factors in...
Source: WHO EMRO News - February 1, 2024 Category: Middle East Health Source Type: news

Why Is HOOKIPA Pharma Stock Trading Lower Today?
HOOKIPA Pharma Inc HOOK will focus its resources on prioritizing the clinical development of a randomized trial for its HB-200 program in human papillomavirus 16 positive (HPV16+) head and neck squamous cell carcinoma (HNSCC) and its two Gilead Science Inc GILD-partnered infectious disease cure…#hookipapharmainchook #gileadscienceinc #hookipa #rocheholdingsag #rhhby #kras #gileadsciences #gilead (Source: Reuters: Health)
Source: Reuters: Health - January 29, 2024 Category: Consumer Health News Source Type: news

No Cervical Cancer After HPV Vax; Brain Tumor Blood Test; Weight Loss and Cancer
(MedPage Today) -- A Scottish study found no cases of invasive cervical cancer in women who were vaccinated against human papillomavirus (HPV) when they were 12 or 13 years old. (Journal of the National Cancer Institute) Meanwhile, women in low... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 26, 2024 Category: Hematology Source Type: news

MRI radiomics help predict cervical cancer treatment outcomes
"Handcrafted" radiomics and deep-learning radiomics based on pretreatment MRI data help predict locally advanced cervical cancer (LACC) concurrent chemoradiotherapy treatment outcomes, according to research published January 12 in Scientific Reports. The study results show promise for tailoring care for patients with this particular cancer, wrote a team led by Sungmoon Jeong, PhD, of Kyungpook National University, Daegu, South Korea. "Our findings may contribute to the development of personalized treatment strategies for locally advanced cervical cancer patients," the group noted. Cervical cancer is the fourth most comm...
Source: AuntMinnie.com Headlines - January 17, 2024 Category: Radiology Authors: Kate Madden Yee Tags: Advanced Visualization Genitourinary Radiology Source Type: news

ACS: Cancer mortality declines, but incidence rates rise
Overall cancer mortality continues to decline, but incidence rates are up, according to a January 17 report by the American Cancer Society (ACS). The report shows that there have been more than four million fewer deaths from cancer in the U.S. since 1991. However, it also showed increased incidence for six of the top 10 cancers as the projected number of new diagnoses is over two million for the first time. “I think we’re all grappling with what the environmental factor that is changing the cancer incidence and mortality among the young," said ACS chief scientific officer William Dahut, MD, at a press conference. AC...
Source: AuntMinnie.com Headlines - January 17, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Subspecialties CT Breast Imaging Source Type: news

Govt says yet to take decision on roll-out of HPV vaccination against cervical cancer
The Union Health Ministry in India clarified that it has not yet made a decision regarding the rollout of the Human Papillomavirus (HPV) vaccination against cervical cancer in the country. Dismissing media reports speculating about a vaccination campaign in the second quarter of 2024 for girls aged 9-14, the ministry stated that such reports are untrue. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 13, 2024 Category: Pharmaceuticals Source Type: news

Community Cancer Centers Treating More HPV-Related Head, Neck Cancer
THURSDAY, Jan. 11, 2024 -- Treatment of human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma has recently shifted to community cancer centers, with an increase in the proportion of nonsurgical treatment and worse overall... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 11, 2024 Category: Pharmaceuticals Source Type: news

Molecular HPV Testing: 6.6% Revenue Growth 2023-2028, reports Kalorama Information
"The World Market for Molecular Diagnostics, 12th Edition" is now on sale by Kalorama Information. ARLINGTON, Va., Jan. 11, 2024 /PRNewswire-PRWeb/ -- Human papillomavirus (HPV) testing is a key segment of the double-digit, multi-billion-dollar global molecular diagnostic testing market,... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 11, 2024 Category: Pharmaceuticals Tags: SVY Source Type: news